Osaic Holdings’s Indaptus Therapeutics INDP Stock Holding History

Osaic Holdings’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1	Closed	-$35	–	7515
2023 Q1	$35	Hold	1	–	–	﹤0.01%	7398
2022 Q4	$0	Hold	1	–	–	﹤0.01%	7302
2022 Q3	$0	Hold	1	–	–	﹤0.01%	7377
2022 Q2	$0	Buy	+1	New	+$78	﹤0.01%	7466
2022 Q1	–	Sell	-3	Closed	–	–	7354
2021 Q4	$0	Buy	3 +1	+50%	+$186	﹤0.01%	7469
2021 Q3	$0	Hold	2	–	–	﹤0.01%	7240
2021 Q2	$1K	Hold	2	–	–	﹤0.01%	6851
2021 Q1	$1K	Hold	2	–	–	﹤0.01%	6662
2020 Q4	$1K	Hold	2	–	–	﹤0.01%	6221
2020 Q3	$1K	Hold	2	–	–	﹤0.01%	6017
2020 Q2	$1K	Buy	+2	New	+$1.24K	﹤0.01%	5946

Other funds holding INDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $1.92B AUM 23.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Strategy Asset Managers Pasadena, California $609M AUM 32.56% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings's INDP Position: Q2 2023 in Review

Osaic Holdings sold out of Indaptus Therapeutics (INDP) in Q2 2023, closing a stake of 1 share — an estimated $35 sold.

Osaic Holdings first reported a position in INDP in Q2 2020 and held it in 11 quarters. The position peaked at $1K in Q2 2021. 14 funds tracked by Wall St. Rank hold INDP as of Q2 2023.

Osaic Holdings reported no remaining Indaptus Therapeutics position as of Q2 2023 after selling out during the quarter.
Osaic Holdings sold 1 Indaptus Therapeutics share in Q2 2023, an estimated $35.
Osaic Holdings first reported a position in Indaptus Therapeutics in Q2 2020 and held it in 11 quarters.
Osaic Holdings's Indaptus Therapeutics position peaked at $1K in Q2 2021.
14 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.